Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2024

Open Access 01-12-2024 | Idiopathic Pulmonary Fibrosis | Research

Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection

Authors: Chuan Huang, Yao-Guang Sun, Chao Ma, Peng Jiao, Qing-Jun Wu, Wen-Xin Tian, Han-Bo Yu, Hong-Feng Tong

Published in: Journal of Cardiothoracic Surgery | Issue 1/2024

Login to get access

Abstract

Background

Patients of interstitial lung disease (ILD) combined with pulmonary lesions are increasingly common in clinical practice. Patients with ILD are at significantly higher risk for complications after pulmonary resection (including lobectomy and sublobar resection), especially acute exacerbations of ILD (AE-ILD). The purpose of this study is to summarize the short-term and long-term outcomes after pulmonary resection in ILD patients and to analyze the clinical factors affecting surgical safety.

Methods

From January 2004 to January 2022, a total of 78 patients who were diagnosed with ILD and underwent pulmonary resection at our center were enrolled in this study. Clinical data, pathological findings, surgical procedures, and intraoperative safety of these patients were collected retrospectively. Postoperative 90-day complications and mortality, long-term surgical outcomes from postoperative 90 days to 24 months, and changes in ILD condition were investigated. Logistic regression analysis was used to identify the risk factors associated with postoperative complications.

Results

The median age of patients was 66.5 (range 33–86) years, 82.1% (64/78) of patients were male, and 78.2% (61/78) of patients had comorbidities. Idiopathic ILD and secondary ILD accounted for 86% and 14%, thoracotomy and video-assisted thoracoscopic surgery accounted for 12.8% and 87.2%, and lobectomy and sublobar resection accounted for 37.2% and 62.8%, respectively. Postoperative 90-day complications occurred in 25.6% (20/78) of patients, with pulmonary complications and AE-ILD occurring in 15.4% and 9.0% of patients, respectively. The postoperative 90-day mortality rate was 5.1% (4/78), and the cause of death was AE-ILD. Exacerbation of ILD or other complications occurred in 12.8% (10/78) of patients from postoperative 90 days to 24 months. Univariate logistic regression analysis showed that comorbidity, extent of resection, systemic lymph node dissection, operation time, intraoperative blood loss, and pathology of pulmonary lesion were associated with postoperative 90-day complications. In multivariate logistic regression analysis, age-adjusted Charlson Comorbidity Index and intraoperative blood loss were identified as independent risk factors of postoperative 90-day complications.

Conclusions

Patients with ILD have a significantly higher risk of postoperative 90-day complications and mortality after pulmonary resection, especially pulmonary complications and AE-ILD. After postoperative 90 days, the risk of deterioration of pulmonary status remains high, including exacerbation of ILD and complications associated with long-term use of glucocorticoids and immunosuppressant. Age, comorbidity and intraoperative blood loss are high risk factors for postoperative 90-day complications.
Literature
1.
go back to reference Wallis A, Spinks K. The diagnosis and management of interstitial lung diseases. BMJ. 2015;350:h2072.CrossRefPubMed Wallis A, Spinks K. The diagnosis and management of interstitial lung diseases. BMJ. 2015;350:h2072.CrossRefPubMed
2.
go back to reference Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46(3):795–806.CrossRefPubMed Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46(3):795–806.CrossRefPubMed
3.
go back to reference Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.CrossRefPubMedPubMedCentral Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.CrossRefPubMedPubMedCentral
4.
go back to reference Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet. 2012;380(9842):689–98.CrossRefPubMed Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet. 2012;380(9842):689–98.CrossRefPubMed
6.
go back to reference Naccache JM, Gibiot Q, Monnet I, Antoine M, Wislez M, Chouaid C, et al. Lung cancer and interstitial lung disease: a literature review. J Thorac Dis. 2018;10(6):3829–44.CrossRefPubMedPubMedCentral Naccache JM, Gibiot Q, Monnet I, Antoine M, Wislez M, Chouaid C, et al. Lung cancer and interstitial lung disease: a literature review. J Thorac Dis. 2018;10(6):3829–44.CrossRefPubMedPubMedCentral
7.
go back to reference Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014;147(5):1604–11e3.CrossRefPubMed Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014;147(5):1604–11e3.CrossRefPubMed
8.
go back to reference Chida M, Kobayashi S, Karube Y, Hayama M, Tamura M, Ishihama H, et al. Incidence of acute exacerbation of interstitial pneumonia in operated lung cancer: institutional report and review. Ann Thorac Cardiovasc Surg. 2012;18(4):314–7.CrossRefPubMed Chida M, Kobayashi S, Karube Y, Hayama M, Tamura M, Ishihama H, et al. Incidence of acute exacerbation of interstitial pneumonia in operated lung cancer: institutional report and review. Ann Thorac Cardiovasc Surg. 2012;18(4):314–7.CrossRefPubMed
9.
go back to reference Sato T, Watanabe A, Kondo H, Kanzaki M, Okubo K, Yokoi K, et al. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. J Thorac Cardiovasc Surg. 2015;149(1):64–9. 70.e1–2.CrossRefPubMed Sato T, Watanabe A, Kondo H, Kanzaki M, Okubo K, Yokoi K, et al. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. J Thorac Cardiovasc Surg. 2015;149(1):64–9. 70.e1–2.CrossRefPubMed
10.
go back to reference Sekihara K, Aokage K, Oki T, Omori T, Katsumata S, Ueda T, et al. Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease. Interact Cardiovasc Thorac Surg. 2018;26(4):638–43.CrossRefPubMed Sekihara K, Aokage K, Oki T, Omori T, Katsumata S, Ueda T, et al. Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease. Interact Cardiovasc Thorac Surg. 2018;26(4):638–43.CrossRefPubMed
11.
go back to reference Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The Eighth Edition Lung Cancer Stage classification. Chest. 2017;151(1):193–203.CrossRefPubMed Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The Eighth Edition Lung Cancer Stage classification. Chest. 2017;151(1):193–203.CrossRefPubMed
12.
go back to reference Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.CrossRefPubMed Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.CrossRefPubMed
13.
go back to reference Wright CD, Edwards FH. The Society of thoracic surgeons General thoracic surgery database. Ann Thorac Surg. 2007;83(3):893–4.CrossRefPubMed Wright CD, Edwards FH. The Society of thoracic surgeons General thoracic surgery database. Ann Thorac Surg. 2007;83(3):893–4.CrossRefPubMed
14.
go back to reference Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016;194(3):265–75.CrossRefPubMed Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016;194(3):265–75.CrossRefPubMed
15.
go back to reference Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRefPubMed
16.
go back to reference Miyajima M, Watanabe A, Sato T, Teramukai S, Ebina M, Kishi K, et al. What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection? Surg Today. 2018;48(4):404–15.CrossRefPubMed Miyajima M, Watanabe A, Sato T, Teramukai S, Ebina M, Kishi K, et al. What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection? Surg Today. 2018;48(4):404–15.CrossRefPubMed
17.
go back to reference Miyamura T, Sakamoto N, Kakugawa T, Okuno D, Yura H, Nakashima S, et al. Postoperative acute exacerbation of interstitial pneumonia in pulmonary and non-pulmonary surgery: a retrospective study. Respir Res. 2019;20(1):154.CrossRefPubMedPubMedCentral Miyamura T, Sakamoto N, Kakugawa T, Okuno D, Yura H, Nakashima S, et al. Postoperative acute exacerbation of interstitial pneumonia in pulmonary and non-pulmonary surgery: a retrospective study. Respir Res. 2019;20(1):154.CrossRefPubMedPubMedCentral
18.
go back to reference Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB. In-Hospital mortality after Surgical Lung Biopsy for interstitial lung disease in the United States. 2000 to 2011. Am J Respir Crit Care Med. 2016;193(10):1161–7.CrossRefPubMed Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB. In-Hospital mortality after Surgical Lung Biopsy for interstitial lung disease in the United States. 2000 to 2011. Am J Respir Crit Care Med. 2016;193(10):1161–7.CrossRefPubMed
19.
go back to reference Fibla JJ, Brunelli A, Cassivi SD, Deschamps C. Aggregate risk score for predicting mortality after surgical biopsy for interstitial lung disease. Interact Cardiovasc Thorac Surg. 2012;15(2):276–9.CrossRefPubMedPubMedCentral Fibla JJ, Brunelli A, Cassivi SD, Deschamps C. Aggregate risk score for predicting mortality after surgical biopsy for interstitial lung disease. Interact Cardiovasc Thorac Surg. 2012;15(2):276–9.CrossRefPubMedPubMedCentral
20.
go back to reference Rotolo N, Imperatori A, Poli A, Nardecchia E, Castiglioni M, Cattoni M, et al. Assessment of the aggregate risk score to predict mortality after surgical biopsy for interstitial lung disease†. Eur J Cardiothorac Surg. 2015;47(6):1027–30. discussion 30.CrossRefPubMed Rotolo N, Imperatori A, Poli A, Nardecchia E, Castiglioni M, Cattoni M, et al. Assessment of the aggregate risk score to predict mortality after surgical biopsy for interstitial lung disease†. Eur J Cardiothorac Surg. 2015;47(6):1027–30. discussion 30.CrossRefPubMed
21.
go back to reference Sato T, Kondo H, Watanabe A, Nakajima J, Niwa H, Horio H, et al. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg. 2015;63(3):164–72.CrossRefPubMed Sato T, Kondo H, Watanabe A, Nakajima J, Niwa H, Horio H, et al. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg. 2015;63(3):164–72.CrossRefPubMed
22.
go back to reference Ueno F, Kitaguchi Y, Shiina T, Asaka S, Yasuo M, Wada Y, et al. The interstitial lung disease-gender-age-physiology index can predict the prognosis in surgically resected patients with interstitial lung disease and concomitant Lung Cancer. Respiration. 2020;99(1):9–18.CrossRefPubMed Ueno F, Kitaguchi Y, Shiina T, Asaka S, Yasuo M, Wada Y, et al. The interstitial lung disease-gender-age-physiology index can predict the prognosis in surgically resected patients with interstitial lung disease and concomitant Lung Cancer. Respiration. 2020;99(1):9–18.CrossRefPubMed
23.
go back to reference Sugiura H, Takeda A, Hoshi T, Kawabata Y, Sayama K, Jinzaki M, et al. Acute exacerbation of usual interstitial pneumonia after resection of lung cancer. Ann Thorac Surg. 2012;93(3):937–43.CrossRefPubMed Sugiura H, Takeda A, Hoshi T, Kawabata Y, Sayama K, Jinzaki M, et al. Acute exacerbation of usual interstitial pneumonia after resection of lung cancer. Ann Thorac Surg. 2012;93(3):937–43.CrossRefPubMed
24.
go back to reference Iwata T, Yoshida S, Fujiwara T, Wada H, Nakajima T, Suzuki H, et al. Effect of Perioperative Pirfenidone Treatment in Lung Cancer patients with idiopathic pulmonary fibrosis. Ann Thorac Surg. 2016;102(6):1905–10.CrossRefPubMed Iwata T, Yoshida S, Fujiwara T, Wada H, Nakajima T, Suzuki H, et al. Effect of Perioperative Pirfenidone Treatment in Lung Cancer patients with idiopathic pulmonary fibrosis. Ann Thorac Surg. 2016;102(6):1905–10.CrossRefPubMed
25.
go back to reference Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–82.CrossRefPubMed Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–82.CrossRefPubMed
26.
go back to reference Iwata T, Yoshino I, Yoshida S, Ikeda N, Tsuboi M, Asato Y, et al. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE study). Respir Res. 2016;17(1):90.CrossRefPubMedPubMedCentral Iwata T, Yoshino I, Yoshida S, Ikeda N, Tsuboi M, Asato Y, et al. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE study). Respir Res. 2016;17(1):90.CrossRefPubMedPubMedCentral
27.
go back to reference Voltolini L, Bongiolatti S, Luzzi L, Bargagli E, Fossi A, Ghiribelli C, et al. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors. Eur J Cardiothorac Surg. 2013;43(1):e17–23.CrossRefPubMed Voltolini L, Bongiolatti S, Luzzi L, Bargagli E, Fossi A, Ghiribelli C, et al. Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors. Eur J Cardiothorac Surg. 2013;43(1):e17–23.CrossRefPubMed
28.
go back to reference Tsutani Y, Mimura T, Kai Y, Ito M, Misumi K, Miyata Y, et al. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg. 2017;154(3):1089–96e1.CrossRefPubMed Tsutani Y, Mimura T, Kai Y, Ito M, Misumi K, Miyata Y, et al. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg. 2017;154(3):1089–96e1.CrossRefPubMed
Metadata
Title
Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection
Authors
Chuan Huang
Yao-Guang Sun
Chao Ma
Peng Jiao
Qing-Jun Wu
Wen-Xin Tian
Han-Bo Yu
Hong-Feng Tong
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2024
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-024-02508-1

Other articles of this Issue 1/2024

Journal of Cardiothoracic Surgery 1/2024 Go to the issue